CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A, Consoli U, Snell V, Clodi K, Kliche KO, Palmer JL, Gruss HJ, Armitage R, Thomas EK, Cabanillas F, Andreeff M.
Younes A, et al. Among authors: clodi k.
J Clin Oncol. 1997 Nov;15(11):3355-62. doi: 10.1200/JCO.1997.15.11.3355.
J Clin Oncol. 1997.
PMID: 9363866
Clinical Trial.